BIlateral juxtapapillary retinal capillary haemangioma: Usefulness of aflibercept in the management of its complications
Arch Soc Esp Oftalmol. 2017 Oct;92(10):477-480.
doi: 10.1016/j.oftal.2016.12.015.
Epub 2017 Jun 23.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Oftalmología, Hospital Virgen del Puerto, Plasencia (Cáceres), España. Electronic address: rafacampospolo@hotmail.com.
- 2 Servicio de Oftalmología, Hospital Virgen del Puerto, Plasencia (Cáceres), España.
Abstract
Case report:
A 45 year-old man with a history of adrenal phaeochromocytoma presented with a subretinal juxtapapillary haemorrhage on his left eye and a small asymptomatic vascular tumour in the contralateral eye. With the mentioned findings, the patient was diagnosed with bilateral retinal capillary haemangioma in the context of a von Hippel Lindau disease. Intravitreal aflibercept was prescribed, with a good outcome of the disease.
Discussion:
Many treatments have been proposed for the management of juxtapapillary retinal capillary haemangioma with variable results. Intravitreal aflibercept can be a useful treatment with a good safety profile.
Keywords:
Aflibercept; Enfermedad de von Hippel Lindau; Feocromocitoma; Hemangioma capilar retiniano; Hemorragia subretiniana yuxtapapilar; Phaeochromocytoma; Retinal capillary haemangioma; Subretinal juxtapapillary haemorrhage; Von Hippel Lindau disease.
Copyright © 2017 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adrenal Gland Neoplasms
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / therapeutic use*
-
Fluorescein Angiography
-
Hemangioma, Capillary / complications*
-
Hemangioma, Capillary / diagnostic imaging
-
Humans
-
Intravitreal Injections
-
Male
-
Middle Aged
-
Neoplasms, Multiple Primary / diagnosis*
-
Neoplasms, Multiple Primary / diagnostic imaging
-
Neoplasms, Multiple Primary / genetics
-
Pheochromocytoma
-
Receptors, Vascular Endothelial Growth Factor / administration & dosage
-
Receptors, Vascular Endothelial Growth Factor / therapeutic use*
-
Recombinant Fusion Proteins / administration & dosage
-
Recombinant Fusion Proteins / therapeutic use*
-
Retinal Hemorrhage / drug therapy*
-
Retinal Hemorrhage / etiology
-
Retinal Neoplasms / complications*
-
Retinal Neoplasms / diagnosis
-
Retinal Neoplasms / diagnostic imaging
-
Retinal Neoplasms / genetics
-
Tomography, Optical Coherence
-
von Hippel-Lindau Disease / complications
-
von Hippel-Lindau Disease / diagnosis
Substances
-
Angiogenesis Inhibitors
-
Recombinant Fusion Proteins
-
aflibercept
-
Receptors, Vascular Endothelial Growth Factor